Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.573 USD | -2.88% | -7.91% | -1.29% |
Apr. 16 | VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 15 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.29% | 16.78M | |
+0.80% | 43.84B | |
+5.26% | 41.68B | |
+45.38% | 41.25B | |
-10.92% | 27.04B | |
+7.25% | 25.53B | |
-25.69% | 18.18B | |
-4.40% | 12.29B | |
+25.09% | 12.29B | |
+6.82% | 11.15B |
- Stock Market
- Equities
- VBIV Stock
- News VBI Vaccines Inc.
- VBI Vaccines : Partners Commence Phase 2 Clinical Trial of BRII-835 in Combination with BRII-179 for Treating Hepatitis B